Break a sweat to reduce cardiotoxicity – the benefits of exercise training during anthracycline chemotherapy

Abstract

Get full access to this article

View all access options for this article.

References

Piepoli

Hoes

Agewall

et al.

2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur J Prev Cardiol 2016; 23: NP1–NP96.

Adams

Iyengar

Scott

et al.

Exercise implementation in oncology: One size does not fit all. J Clin Oncol 2018; 36: 925–926.

Corra

Agostoni

Anker

et al.

Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2018; 20: 3–15.

Zamorano

Lancellotti

Rodriguez Munoz

et al.

2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for Cancer Treatments and Cardiovascular Toxicity of the European Society of Cardiology (ESC). Eur J Heart Fail 2017; 19: 9–42.

Pareek

Cevallos

Moliner

et al.

Activity and outcomes of a cardio-oncology service in the United Kingdom–a five-year experience. Eur J Heart Fail 2018; 20: 1721–1731.

Lancellotti

Suter

Lopez-Fernandez

et al.

Cardio-oncology services: Rationale, organization, and implementation: A report from the ESC Cardio-Oncology council. Eur Heart J. Epub ahead of print 6 August 2018. DOI: 10.1093/eurheartj/ehy453.

Jones

Courneya

Mackey

et al.

Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol 2012; 30: 2530–2537.

Scott

Iyengar

Nilsen

et al.

Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: A randomized controlled trial. Cancer 2018; 124: 2552–2560.

Hornsby

Douglas

West

et al.

Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: A phase II randomized trial. Acta Oncol 2014; 53: 65–74.

10.

Kirkham

Paterson

Prado

et al.

Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: A 3-arm parallel group phase II randomized controlled trial in early breast cancer. BMC Cancer 2018; 18: 864–864.

11.

Lee

Kang

Mortimer

et al.

Effects of high-intensity interval training on vascular function in breast cancer survivors undergoing anthracycline chemotherapy: Design of a pilot study. BMJ Open 2018; 8: e022622–e022622.

12.

Keats

Grandy

Giacomantonio

et al.

EXercise to prevent AnthrCycline-based Cardio-Toxicity (EXACT) in individuals with breast or hematological cancers: A feasibility study protocol. Pilot Feasibility Stud 2016; 2: 44–44.

13.

Howden

Bigaran

Beaudry

et al.

Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients. Eur J Prev Cardiol. 2019; 26: 305–315.

14.

Scott

Zabor

Schwitzer

et al.

Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: A systematic review and meta-analysis. J Clin Oncol 2018; 36: 2297–2305.

15.

Hansen

Dendale

Coninx

et al.

The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology. Eur J Prev Cardiol 2017; 24: 1017–1031.

16.

Piepoli

Conraads

Corra

et al.

Exercise training in heart failure: From theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail 2011; 13: 347–357.

17.

Ameri

Canepa

Anker

et al.

Cancer diagnosis in patients with heart failure: Epidemiology, clinical implications and gaps in knowledge. Eur J Heart Fail 2018; 20: 879–887.